Literature DB >> 20390431

Inflammation in neuroviral diseases.

Pascale Giraudon1, Arlette Bernard.   

Abstract

During any viral infection of the central nervous system (CNS), the extent and nature of neural cell alterations are dictated by the localization of virus replication and, possibly, persistence. However, one additional source of CNS damage comes from the immune response that develops following CNS viral infection. Indeed, despite of its major role in controlling virus spread in the infected CNS, the immune system is equipped with numerous molecular effectors shared with the nervous system that may greatly alter the homeostasis and function of neural cells. Proinflammatory cytokines and metalloproteases belong to this inflammatory cascade. Besides neurovirulence, the crosstalk engaged between neural and immune cells is a major factor determining the outcome of neuroviral infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20390431     DOI: 10.1007/s00702-010-0402-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  88 in total

Review 1.  Matrix metalloproteinase proteomics: substrates, targets, and therapy.

Authors:  Charlotte J Morrison; Georgina S Butler; David Rodríguez; Christopher M Overall
Journal:  Curr Opin Cell Biol       Date:  2009-07-16       Impact factor: 8.382

2.  Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease.

Authors:  M C Levin; T J Lehky; A N Flerlage; D Katz; D W Kingma; E S Jaffe; J D Heiss; N Patronas; H F McFarland; S Jacobson
Journal:  N Engl J Med       Date:  1997-03-20       Impact factor: 91.245

3.  Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system.

Authors:  M A Laurenzi; A Sidén; M A Persson; G Norkrans; L Hagberg; F Chiodi
Journal:  Clin Immunol Immunopathol       Date:  1990-11

Review 4.  Glutamate uptake.

Authors:  N C Danbolt
Journal:  Prog Neurobiol       Date:  2001-09       Impact factor: 11.685

5.  T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease.

Authors:  P Giraudon; R Szymocha; S Buart; A Bernard; L Cartier; M F Belin; H Akaoka
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 6.  Virus-host interaction in the simian immunodeficiency virus-infected brain.

Authors:  Howard S Fox
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

7.  Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.

Authors:  Jenna L Bowen; Julie K Olson
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

8.  Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis.

Authors:  Jessica Carmen; Jeffrey D Rothstein; Douglas A Kerr
Journal:  Brain Res       Date:  2009-02-03       Impact factor: 3.252

Review 9.  Central nervous system infections. The usual and the unusual.

Authors:  J D Lipton; R W Schafermeyer
Journal:  Emerg Med Clin North Am       Date:  1995-05       Impact factor: 2.264

10.  Role of IFN-gamma responsiveness in CD8 T-cell-mediated viral clearance and demyelination in coronavirus-infected mice.

Authors:  Steven P Templeton; Stanley Perlman
Journal:  J Neuroimmunol       Date:  2007-12-21       Impact factor: 3.478

View more
  9 in total

1.  Characteristics of a COVID-19 Cohort With Large Vessel Occlusion: A Multicenter International Study.

Authors:  Pascal Jabbour; Adam A Dmytriw; Ahmad Sweid; Michel Piotin; Kimon Bekelis; Nader Sourour; Eytan Raz; Italo Linfante; Guilherme Dabus; Max Kole; Mario Martínez-Galdámez; Shahid M Nimjee; Demetrius K Lopes; Ameer E Hassan; Peter Kan; Mohammad Ghorbani; Michael R Levitt; Simon Escalard; Symeon Missios; Maksim Shapiro; Frédéric Clarençon; Mahmoud Elhorany; Daniel Vela-Duarte; Rizwan A Tahir; Patrick P Youssef; Aditya S Pandey; Robert M Starke; Kareem El Naamani; Rawad Abbas; Bassel Hammoud; Ossama Y Mansour; Jorge Galvan; Joshua T Billingsley; Abolghasem Mortazavi; Melanie Walker; Mahmoud Dibas; Fabio Settecase; Manraj K S Heran; Anna L Kuhn; Ajit S Puri; Bijoy K Menon; Sanjeev Sivakumar; Ashkan Mowla; Salvatore D'Amato; Alicia M Zha; Daniel Cooke; Mayank Goyal; Hannah Wu; Jake Cohen; David Turkel-Parrella; Andrew Xavier; Muhammad Waqas; Vincent M Tutino; Adnan Siddiqui; Gaurav Gupta; Anil Nanda; Priyank Khandelwal; Cristina Tiu; Pere C Portela; Natalia Perez de la Ossa; Xabier Urra; Mercedes de Lera; Juan F Arenillas; Marc Ribo; Manuel Requena; Mariangela Piano; Guglielmo Pero; Keith De Sousa; Fawaz Al-Mufti; Zafar Hashim; Sanjeev Nayak; Leonardo Renieri; Mohamed A Aziz-Sultan; Thanh N Nguyen; Patricia Feineigle; Aman B Patel; James E Siegler; Khodr Badih; Jonathan A Grossberg; Hassan Saad; M Reid Gooch; Nabeel A Herial; Robert H Rosenwasser; Stavropoula Tjoumakaris; Ambooj Tiwari
Journal:  Neurosurgery       Date:  2022-03-07       Impact factor: 5.315

Review 2.  Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System.

Authors:  Maria Lima; Vasileios Siokas; Athina-Maria Aloizou; Ioannis Liampas; Alexios-Fotios A Mentis; Zisis Tsouris; Anastasios Papadimitriou; Panayiotis D Mitsias; Aristidis Tsatsakis; Dimitrios P Bogdanos; Stavros J Baloyannis; Efthimios Dardiotis
Journal:  Curr Treat Options Neurol       Date:  2020-09-25       Impact factor: 3.598

3.  Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: the particular context of virus infection.

Authors:  Pascale Giraudon; Adeline Nicolle; Sylvie Cavagna; Claire Benetollo; Romain Marignier; Michel Varrin-Doyer
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

Review 4.  Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans.

Authors:  Marc Desforges; Alain Le Coupanec; Elodie Brison; Mathieu Meessen-Pinard; Pierre J Talbot
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

5.  Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019.

Authors:  Ahmad Sweid; Batoul Hammoud; Kimon Bekelis; Symeon Missios; Stavropoula I Tjoumakaris; Michael R Gooch; Nabeel A Herial; Hekmat Zarzour; Victor Romo; Maureen DePrince; Robert H Rosenwasser; Pascal Jabbour
Journal:  Int J Stroke       Date:  2020-06-26       Impact factor: 5.266

6.  Clinical features and corresponding immune function status of recurrent viral polymerase chain reaction positivity in patients with COVID-19 : A meta- analysis and systematic review.

Authors:  Xingxiang Ren; Xiankun Wang; Ziruo Ge; Shuping Cui; Zhihai Chen
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

7.  Construction of AAV-rat-IL4 and Evaluation of its Modulating Effect on Aβ (1-42)-Induced Proinflammatory Cytokines in Primary Microglia and the B92 Cell Line by Quantitative PCR Assay.

Authors:  Marzieh Jamalidoust; Mehrdad Ravanshad; Mandana Namayandeh; Maryam Zare; Sadaf Asaei; Mazyar Ziyaeyan
Journal:  Jundishapur J Microbiol       Date:  2016-03-05       Impact factor: 0.747

Review 8.  Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis.

Authors:  Marc Desforges; Alain Le Coupanec; Jenny K Stodola; Mathieu Meessen-Pinard; Pierre J Talbot
Journal:  Virus Res       Date:  2014-10-02       Impact factor: 3.303

Review 9.  Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?

Authors:  Marc Desforges; Alain Le Coupanec; Philippe Dubeau; Andréanne Bourgouin; Louise Lajoie; Mathieu Dubé; Pierre J Talbot
Journal:  Viruses       Date:  2019-12-20       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.